Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Exclusion Criteria

• •1. Actively participation in investigational drug treatment for non-alcoholic fatty liver disease
• •2. Currently taking medications for weight loss or have joined a supervised weight loss program prior to enrollment
• •3. Have hepatocellular carcinoma and are undergoing therapy
• •4. Women who become pregnant or plan to become pregnant prior to the study date; female subjects who become pregnant during the study will be withdrawn from the study
• •5. Pacemaker or implantable cardioverter devices
• •6. History of hepatic surgery
• •7. Current significant alcohol consumption, defined as more than 20 grams per day in females or 30 grams per day in males
• •8. Presence of ascites or hepatic encephalopathy
• •9. Symptomatic gastroparesis
• •10. Uncontrolled diabetes, as defined by a HgbA1C \>11%
• •11. Uncontrolled congestive heart failure
• •12. Active infections
• •13. Child Turcotte Pugh score \> 6
• •14. MELD score \>12
• •15. Unwilling to undergo an MRI or have contraindications to an MRI